skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.

Using the same extended sports metaphor as the R&D Annual Review 2019, our expert analyst takes you into the world of new chemical or biological entities where the active ingredient had received no prior approval for human use until 2018. Take a look at which new active substance (NAS) drugs, including vaccines with novel antigenic components, crossed the finish line and made it to market last year. Information within this resource includes:

 

  • Critical statistics about 2018’s 68 NAS launches
  • Top companies with NAS launches last year
  • NAS launches by therapeutic group
  • NAS launches by region
  • A year-over-year look at NAS launches with an orphan drug designation
  • Notable firsts among this year’s field of NAS launches
NAS_supplement_whitepaper

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

または下記のフォームよりご連絡下さい。

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。